---
figid: PMC5566756__oop-0003-0133-g01
figlink: /pmc/articles/PMC5566756/figure/F1/
number: F1
caption: The MAPK pathway. Following activation of growth factor receptors by their
  ligands, signal transduction through the Ras-Raf-MEK-MAPK pathway occurs. With the
  help of Myc and CREB, signals are passed on to the nucleus and lead to transcription
  of genes that are relevant in proliferation and tumorigenesis. BRAF inhibition tackles
  signal transduction from Raf to MEK, whereas further downstream, MEK inhibition
  stops signal transduction from MEK to MAPK, thus counteracting resistance mechanisms
  that bypass Raf inhibition. L, ligand of growth factor receptor; GF-R, growth factor
  receptor; BI, BRAF inhibitor; MI, MEK inhibitor; CREB, cAMP response element-binding
  protein.
pmcid: PMC5566756
papertitle: Systemic BRAF/MEK Inhibitors as a Potential Treatment Option in Metastatic
  Conjunctival Melanoma.
reftext: Joel M. Mor, et al. Ocul Oncol Pathol. 2017 Jul;3(2):133-141.
pmc_ranked_result_index: '93801'
pathway_score: 0.9161261
filename: oop-0003-0133-g01.jpg
figtitle: The MAPK pathway
year: '2017'
organisms:
- Homo sapiens
ndex: 3fabe1b6-de8f-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5566756__oop-0003-0133-g01.html
  '@type': Dataset
  description: The MAPK pathway. Following activation of growth factor receptors by
    their ligands, signal transduction through the Ras-Raf-MEK-MAPK pathway occurs.
    With the help of Myc and CREB, signals are passed on to the nucleus and lead to
    transcription of genes that are relevant in proliferation and tumorigenesis. BRAF
    inhibition tackles signal transduction from Raf to MEK, whereas further downstream,
    MEK inhibition stops signal transduction from MEK to MAPK, thus counteracting
    resistance mechanisms that bypass Raf inhibition. L, ligand of growth factor receptor;
    GF-R, growth factor receptor; BI, BRAF inhibitor; MI, MEK inhibitor; CREB, cAMP
    response element-binding protein.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CREB3L1
  - CREB3L3
  - MAPK8
  - MAPK9
  - CREB1
  - MAPK10
  - MAPK11
  - ATF2
  - CREB3L2
  - MAP2K1
  - MAP2K2
  - CREB5
  - RAPGEF5
  - MAPK14
  - MAPK1
  - MAPK3
  - KRAS
  - HRAS
  - CREB3
  - MAPK13
  - MAPK12
  - CREB3L4
  - ATF1
  - RAF1
  - MYC
  - BRAF
  - ARAF
  - NRAS
  - CREM
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: GF-R
  symbol: GFR
  source: hgnc_alias_symbol
  hgnc_symbol: RAPGEF5
  entrez: '9771'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Myc
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5566756__F1
redirect_from: /figures/PMC5566756__F1
figtype: Figure
---
